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INTRODUCTION
Video-assisted thoracic surgery (VATS), which is known to
be less invasive than conventional thoracotomy, causes less
pain and better preservation of pulmonary function (1-4).
However, patients can still experience considerable pain fol-
lowing VATS (5, 6). There are several studies to compare the
efficacy of different analgesic methods in patients undergoing
conventional thoracotomy. It has been demonstrated that tho-
racic epidural analgesia is more effective than systemic opi-
oids in terms of pain relief (7, 8) or preservation of spiromet-
ric function (9). But there are few studies to compare the effi-
cacy of different analgesic methods in patients undergoing
VATS. It is well known that the thoracic epidural technique
has the risk of dura puncture, epidural hematoma, nerve dam-
age, and unsuccessful catheter placement (10, 11). Adminis-
tration of intravenous (IV) patient controlled analgesia (PCA)
is less invasive than epidural PCA, therefore, IV PCA would
be preferable if it has similar analgesic effect compared to epi-
dural PCA. Therefore, we conducted this prospective study
to compare the efficacy of IV PCA and epidural PCA for the
management of postoperative pain caused by VATS. 
MATERIALS AND METHODS
After receiving approval from the Institutional Review
Board and written, informed consent, 52 patients with lung
cancer scheduled to undergo VATS lobectomy were enrolled.
Patients with significant pre-operative pulmonary dysfunction,
severe cardiovascular, hepatic, renal, musculo-skeletal disease,
or more than 75-yr-old patients were excluded. 
A computer-generated table was used to randomly assign
the patients into two groups of 26: the Epidural PCA group
and the IV PCA group. Patients in the Epidural PCA group
had an epidural catheter that was inserted between 5th and
6th thoracic vertebra or 6th and 7th prior to the induction
of anesthesia. We excluded intravascular or intrathecal catheter
placement with a test dose of 3 mL lidocaine (2%) with 1:
200,000 epinephrine. 
All patients received the 5 mg/kg of thiopental sodium,
IV, followed by 2 μ g/kg of fentanyl, and 0.1 mg/kg of vecuro-
nium. A left-sided double-lumen endobronchial tube (Bron-
cho-CathTM, Mallinckrodt, Athlone, Ireland) was inserted into
all patients and anesthesia was then maintained with sevoflu-
rane 2-4 vol% in a mixture of 50% oxygen and 50% air. Ex-
930
Jie Ae Kim, Tae Hyeong Kim, 
Mikyung Yang, Mi Sook Gwak, 
Gaab Soo Kim, Myung Joo Kim, 
Hyun Sung Cho, and Woo Seok Sim  
Department of Anesthesiology and Pain Medicine,
Samsung Medical Center, Sungkyunkwan University
School of Medicine, Seoul, Korea
Address for correspondence
Mikyung Yang, M.D.
Department of Anesthesiology and Pain Medicine,
Samsung Medical Center, Sungkyunkwan University
School of Medicine, 50 Irwon-dong, Gangnam-gu,
Seoul 135-720, Korea
Tel : +82.2-3410-6590, Fax : +82.2-3410-6626
E-mail : anesyang@skku.edu
J Korean Med Sci 2009; 24: 930-5
ISSN 1011-8934
DOI: 10.3346/jkms.2009.24.5.930
Copyright � The Korean Academy
of Medical Sciences
Is Intravenous Patient Controlled Analgesia Enough for Pain Control
in Patients Who Underwent Thoracoscopy?
This prospective randomized study was conducted to evaluate the efficacy of two
common analgesic techniques, thoracic epidural patient-controlled analgesia (Epidu-
ral PCA), and intravenous patient-controlled analgesia (IV PCA), in patients under-
going lobectomy by the video-assisted thoracic surgical (VATS) approach. Fifty-two
patients scheduled for VATS lobectomy were randomly allocated into two groups:
an Epidural PCA group receiving an epidural infusion of ropivacaine 0.2%+fentanyl
5 μ g/mL combination at a rate of 4 mL/hr, and an IV PCA group receiving an intra-
venous infusion of ketorolac 0.2 mg/kg+fentanyl 15 μ g/mL combination at a rate
of 1 mL/hr. Pain scores were then recorded using the visual analogue scale at rest
and during motion (VAS-R and VAS-M, 0-10) for five days following surgery. In addi-
tion, we measured the daily morphine consumption, forced vital capacity (FVC),
forced expiratory volume in 1 second (FEV1), satisfaction score, and the incidence
of side effects. Thirty-seven patients out of 52 completed the study (18 in the Epidu-
ral PCA group, 19 in the IV PCA group). There were no differences in the pain scores,
analgesic requirements, pulmonary function, satisfaction score, and the incidence
of side effects between groups. This indicates that IV PCA and Epidural PCA are
equally effective to control the postoperative pain after VATS lobectomy, which sug-
gests that IV PCA may be used instead of Epidural PCA.
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cept for opioids used at induction of anesthesia, initial load-
ing of PCA, and continuous infusion of PCA, no additional
opioids were administered during the maintenance of anes-
thesia. All operations were performed by one surgeon using
same technique. The first analgesia dose was administered
immediately after induction of anesthesia. In the Epidural
PCA group, a 6 mL bolus of ropivacaine (0.2%) with 50 μ g
fentanyl was administered via the epidural catheter ten min-
utes prior to surgical incision. Immediately after this, an epi-
dural infusion of 2,500 μ g of fentanyl in 500 mL of 0.2%
ropivacaine was started through the epidural catheter at a
basal infusion rate of 4 mL/hr with an Abbott infusion pump
(Aim
�plus, Abbott Laboratories, U.S.A.). In the IV PCA
group, a bolus of 1 μ g/kg fentanyl (Guju Pharm., Hwaseong,
Korea) with 0.2 mg/kg ketorolac was administered prior to
surgery. Immediately after this, intravenous infusion of 1,500
μ g of fentanyl with 300 mg of ketorolac in 100 mL of nor-
mal saline was started at a basal infusion rate of 1.0 mL/hr
with an IV infusion pump (AutoMed
�3200, Ace Medical,
Korea). The analgesic bolus of PCA (using a 3 mL bolus and
a lock-out time of 15 min in the Epidural PCA group and
using a 1.0 mL bolus and a lock-out time of 15 min in the
IV PCA group) was not administered during the operation,
and started at postanesthesia care unit (PACU) by the patient
after awakening.
The patient’s pain intensity both at rest and during move-
ment (VAS-R, VAS-M) was measured using a 10 cm non-
graduated visual analogue scale at PACU one hour after oper-
ation and then daily for the first five days following surgery.
Breakthrough pain that occurred during this period was treat-
ed by intravenous administration of 4 mg of morphine by
nurses on demand. Total administered morphine doses were
recorded, along with the incidence of nausea, vomiting, som-
nolence, dizziness, and pruritus. The incidence of respiratory
depression, which was defined as a respiratory rate of <ten
breaths/min, was also recorded. 
In addition, the forced vital capacity (FVC) and forced ex-
pired volume in 1 second (FEV1) were measured at the pre-
operative visit and again on the first, second, and third post-
operative days using a portable spirometer (Micro, Micro Med-
ical Limited, Rochester, U.K.). Three measurements were
taken on each day with the patient in a sitting position. The
FVC and FEV1 recovery rates were expressed by determining
the percentage of predicted values that were calculated based
on number of resected pulmonary segments (1). Postopera-
tive chest radiography were also taken for five days, and the
incidence of atelectasis and pneumonia were recorded. 
The patients were then asked to rank their satisfaction re-
garding their pain management on the fifth postoperative
day according to the following scale: 0=very unsatisfactory,
1=unsatisfactory, 2=neutral, 3=satisfactory, 4=very satisfac-
tory. All postoperative assessments were performed by one
technician who did not know the purpose of this study.
An a priori- power analysis with a power of 80% and a Type
I error of 5% was conducted to determine the number of pa-
tients in each group that would be required to detect a 3 mg
difference in the morphine requirement with an assumed
standard deviation (SD) of 3. The results of this analysis indi-
cated that seventeen patients per group would be required to
detect such a difference, therefore, 26 patients were enrolled
into each group because the dropout rate during the postop-
erative follow up was assumed to be 35% in the previous other
study.
The patient characteristics between two groups were com-
pared using a Student’s t-test. Differences in the incidence of
side-effects were compared using the chi-square test or Fish-
er’s exact test. The VAS scores, the daily dose of rescue anal-
gesic drugs and spirometry data were compared using two-
way repeated-measures ANOVA, with the Holm-Sidak test
being used for intragroup comparisons. The data are present-
ed as mean±SD or number where appropriate. A probabil-
ity of <0.05 was considered to be significant and Jandel Sig-
ma Stat (version 3.0, Jandel Corporation, San Rafael, CA,
U.S.A.) was used for all statistical analyses.
RESULTS
Of the 52 patients enrolled, 37 completed the study (18 in
Epidural PCA Group, and 19 in IV PCA Group). Five pati-
ents (three in the Epidural PCA group and two in the IV PCA
group) were withdrawn because the operation was changed
into thoracotomy to control bleeding. Four patients (one in
the Epidural PCA group and three in the IV PCA group) were
withdrawn because they received talc pleurodesis after oper-
ation. In addition, four patients (two in each group) asked to
stop PCA because of severe nausea and vomting. One patient
in the Epidural PCA group did not complete the study because
he underwent postoperative mechanical ventilation. Finally,
one patient in the Epidural PCA group did not complete the
study because of accidental removal of the epidural catheter.
There were no significant differences in the patient char-
acteristics and operation data between the two groups (Table
1). The pain scores were not different between the two groups
(Fig. 1) and the need for rescue analgesics over the entire ob-
Parameters
Epidural PCA 
(n=18)
IV PCA 
(n=19)
Age (yr) 52.3±8.3 52.4±13.7
Sex (male/female)  11/7 9/10
Body weight (kg)  63.3±7.9 62.4 ±11.7
Height (cm)  164.9±8.3 162.9±8.8
Op duration (min)  157±38 152±28
Table 1. Characteristics and surgical data of the patients
Values are mean±SD or number of patients. There are no significant
differences between two groups.
IV, intravenous; PCA, patient-controlled analgesia; Op, operation. 932 J.A. Kim, T.H. Kim, M. Yang, et al.
servation period was not different between the two groups
(Fig. 2). Additionally, the percentage changes in the FVC
and FEV1 compared to the predicted values were similar in
the two groups (Fig. 3). Furthermore, the average satisfaction
score did not differ significantly (3.1±0.7 in the Epidural
PCA group, 3.2±0.6 in the IV PCA group, respectively).
Finally, the incidence of nausea, vomiting, dizziness, somno-
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Fig. 1. Mean visual analogue scores (VAS) at rest and during move-
ment. Error bars indicate standard error mean. There are no sig-
nificant differences between two groups. 
IV, intravenous; PCA, patient-controlled analgesia.
Epidural PCA
IV PCA
Fig. 2. Mean daily doses of intravenous morphine given as a res-
cue medication. Error bars indicate standard error mean. There
are no significant differences between two groups. 
IV, intravenous; PCA, patient-controlled analgesia.
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Fig. 3. Mean percentage changes in forced vital capacity (FVC)
and forced expiratory volume in 1 second (FEV1). Error bars indi-
cate standard error mean. There are no significant differences
between two groups. 
IV, intravenous; PCA, patient-controlled analgesia; POD, post-oper-
ative day. 
Values are number of patients (percentages). There are no significant
differences between two groups.
IV, intravenous; PCA, patient-controlled analgesia.
Epidural PCA 
(n=18)
Symptoms/signs
IV PCA 
(n=19)
P value
Dizziness 9 (50%) 11 (58%) 0.880
Somnolence 6 (33%) 10 (53%) 0.394
Pruritus 7 (39%) 6 (32%) 0.904
Nausea 4 (22%) 9 (47%) 0.209
Vomiting 2 (11%) 3 (16%) 0.948
Atelectasis 4 (22%) 6 (31%) 0.787
Pneumonia 1 (6%) 0 (0%) 0.977
Respiratory depression 0 (0%) 0 (0%) 1.000
Table 2. Incidence of side-effects and postoperative complica-
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lence, pruritus, atelectasis, pneumonia, and respiratory depres-
sion were similar in the two groups (Table 2).
DISCUSSION
Patient-controlled thoracic epidural analgesia is the most
effective mode of postoperative analgesia after thoracotomy
(7). However, its use in less invasive VATS has not been wide-
ly explored. We investigated whether thoracic epidural anal-
gesia has more benefit than IV PCA in postoperative pain
management in patients undergoing VATS for primary lung
cancer.
Our results suggest that the benefits of IV PCA in terms
of the pain score, consumption of analgesics, restoration of
pulmonary function, and satisfaction were equal to those of
epidural PCA in patients undergoing VATS. Although these
results do not agree with those of other studies that compared
epidural PCA with IV PCA in patients who received thora-
cotomy (7-9), this may be due to different types of surgery.
It is well known that VATS causes less tissue damage and
respiratory dysfunction than thoracotomy (12, 13), therefore,
the pain caused by VATS may be less severe and effectively
controlled by IV PCA. 
Based on this assumption, we reviewed previous studies
that compared the use of IV PCA and epidural PCA in pati-
ents that underwent laparotomy, which is also assumed to
cause less pain than thoracotomy. Aygun and colleagues (14)
compared the effects of IV tramadol, IV fentanyl, epidural
tramadol, and epidural fentanyl in patients that underwent
lower abdominal surgery and found that adequate analgesia
was achieved in all groups, but that IV tramadol and fentanyl
were associated with a high incidence of nausea and vomiting.
In our study, although there were slightly higher tendencies
for nausea and vomiting in the IV PCA group, these differ-
ences were not significant. 
We determined the analgesic regimen of each method re-
ferring to the most common and popular recommendations
(15). According to a study comparing the efficacy of epidural
and intravenous fentanyl administration using patient-con-
trolled analgesia, pain scores and fentanyl plasma concentra-
tions did not differ between the two routes of administration
(16). In addition, Coda et al. (17) concluded that epidural
administration of lipophilic opioids might offer no clinical
advantage over the intravenous route. The amount of fentanyl
administered in our study was not equal in two groups. We
administered 20 μ g/hr of fentanyl in Epidural PCA group
compared to 15 μ g/hr of fentanyl in IV PCA group because
Geller et al. (18) had reported that more intense degree of
sedation and the risk of respiratory depression was associated
with intravenous sufentanil than epidural sufentanil. There-
fore, we reduced the amount of fentanyl administered by in-
travenous route. We do not think the slight difference of the
administered amount of fentanyl would affect the conclusion
of our study because the exact comparison of the efficacy of
the route of administration was not the aim of our study.
Several methods for pain management after thoracoscopic
surgery have been suggested. Perttunen et al. (5) reported
that two-day IV infusion of diclofenac or ketorolac was effec-
tive to reduce total morphine consumption. Vogt et al. (19)
and Hill et al. (20) have reported that a single-injection tho-
racic paravertebral block improved postoperative pain. Addi-
tionally, Ziser and others (21) attempted to determine the
doses of parenteral analgesics administered after VATS retros-
pectively and found that 25.8±11.6 mg/m2 of morphine
equivalent was administered during the first 24 hr, suggest-
ing that higher opioid doses than previously anticipated were
required. They also reported that patients of younger age, fe-
male gender, and use of patient-controlled analgesia received
higher doses of analgesics. However, none of the above cited
studies compared the recommended methods with the use
of thoracic epidural PCA that has been known as most effec-
tive method, thus lacking the relative efficacy of the meth-
ods they elicited. When Furrer and co-workers (22) evaluat-
ed the use of epidural PCA for patients undergoing thoraco-
tomy and IV PCA for patients undergoing thoracoscopy, res-
pectively, they found that the pain score and restoration of
pulmonary function were similar in both groups. 
Some contradicting results regarding the efficacy of epidu-
ral analgesia after VATS have been reported. Fernandez and
colleagues (23) reported that the use of a patient-controlled
epidural analgesia in patients undergoing VATS pleurecto-
my was as effective as parenteral opioids, but did not confer
any additional benefits to other less invasive methods of anal-
gesia. This result is comparable to the results of the present
study, however, the procedures used in their study involved
more minimal access than those used in our study. Converse-
ly, Yoshioka and others (24) reported that epidural analgesia
is more effective than non-epidural analgesia for pain control
until post-operative day (POD) 1 after VATS, especially for
pain on movement. Based on their results, they recommend-
ed epidural analgesia be used until POD 1, but that other
analgesic method should be employed beginning on POD
2 because of the high incidence of nausea and vomiting asso-
ciated with epidural analgesia. However, in our study, we did
not observe any differences in pain score or analgesic consum-
ption between two groups even on POD 1.
The number of ports, the size and location of incision, and
the duration of VATS can be varied considerably by the sur-
geons, so we included only the patients who received VATS
from the most skillful surgeon to eliminate possible confoun-
ders. Three ports (4 cm, 10 mm, 5 mm) were used, scattered
over two or three intercostal spaces. No ribs were resected
and no rib-spread technique was used. The number of ports,
size of incision, and duration of VATS were considerably lower
than other studies (1, 4, 12). Not to use invasive method of
surgery makes us to consider the change the methods of pain
management to less invasive one.934 J.A. Kim, T.H. Kim, M. Yang, et al.
Nakata et al. (4) reported that FVC and FEV1 of the pati-
ents restored 85-90% of predicted values at POD 7. Accord-
ing to Furrer et al. (22), FVC and FEV1 measured at POD 1
ranged 59-64% and nearly reached preoperative values at the
time of discharge. Our patients recovered 60-70% of predict-
ed value at POD 1 and did not show further improvement
until POD 3. Because we did not check the FVC and FEV1
after POD 3, direct comparison with above studies was im-
possible. The reason why we did not check the FVC and FEV1
after POD 3 is that we assumed if the difference in restora-
tion of pulmonary function between groups exist, it would
appear in acute postoperative period. 
Our study has several limitations. First, our study was not
blinded because blinding was not practically possible. Sec-
ond, we asked the pain scores 1 hr after operation and 24 hr
after operation, but not between 1 hr and 24 hr after opera-
tion. Senagore and co-workers (25) reported improved pain
control in a group that received epidural PCA when com-
pared to that of a group that received parenteral opioids at 6
hr and 18 hr after laparoscopic segmental colectomy, but no
alteration in the length of the hospital stay between groups.
In addition, Perttunen et al. (5) or Yoshioka and others (24)
also reported that patients who received VATS experienced
moderate or severe pain immediately after operation and that
epidural PCA was more effective at managing pain during
this period. Therefore, in our study a difference in the two
techniques may have occurred during this period and not been
detected. However, we assume the difference was not great
because the cumulative morphine consumption on POD 1
did not differ between two groups. 
In conclusion, IV PCA is as equally effective as Epidural
PCA in patients undergoing VATS lobectomy, therefore, it
may replace Epidural PCA.
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